Sunridge Medical · Scottsdale, Arizona
Squamous Cell Skin Cancer Treatment Support
If you have squamous cell skin cancer, call us. High-risk features and immune status matter.
Cutaneous squamous cell carcinoma ranges from localized disease to uncommon but serious regional or metastatic cancer. Tumor location, size, depth, nerve involvement, recurrence and immune suppression influence risk.
New diagnoses, recurrence, advanced disease and second-opinion questions are welcome.
Talk With Our Squamous Cell Carcinoma Patient Care Team
There is no charge to ask practical questions about your diagnosis, learn how Sunridge works and determine whether a physician consultation may be an appropriate next step.
Cutaneous squamous cell carcinoma ranges from localized disease to uncommon but serious regional or metastatic cancer. Tumor location, size, depth, nerve involvement, recurrence and immune suppression influence risk.
Why the Exact Diagnosis Matters
Pathology and examination should clarify margins and high-risk features. Lymph-node assessment or imaging may be appropriate when the tumor has aggressive characteristics.
Diagnosis details
Pathology, stage, molecular findings and the pattern of disease should be reviewed together.
Treatment context
Previous response, current medications, organ function and clinical-trial options can affect the next step.
Whole-person needs
Nutrition, strength, symptoms, recovery and quality of life belong in the plan.
What Shapes the Treatment Plan
Surgery remains important for many localized tumors. Radiation, systemic therapy or multidisciplinary oncology review may be considered for selected advanced or recurrent disease.
How Sunridge May Fit Into Your Care
Sunridge may help address nutrition, healing, treatment tolerance and interaction questions alongside appropriate skin-cancer treatment.
Talk With Someone Before the Next Decision
Our Patient Care Team can explain what records to send and whether a physician consultation may be an appropriate next step.
Questions Worth Bringing to the Consultation
- What does the pathology show, and has it been reviewed by the right specialist?
- Which findings determine risk and the recommended treatment sequence?
- How will response and side effects be monitored?
- Which supplements, IV therapies or supportive treatments could interact with the oncology plan?